@qol.eortc.org
The EORTC Quality of Life Group (QLG) aims to better understand the effects of cancer and its treatments on health-related quality of life (HRQoL) for patients across diverse populations and cultures.
👋 Attending #SIOPCongress this week?
📢 Catch tomorrow's presentation by @eortc.org #QualityofLife Group (QLG) member Anne-Sophie Darlington about a new EORTC QLG questionnaire aimed to measure all QoL issues of relevance and importance to AYAs aged 14-39 years with cancer.
@worldsiop.bsky.social
👏 Congratulations to our @eortc.org #QualityofLife Group members Veronika Engele & Louis Fox for their great presentations at #ESMO25.
🏅 And well done Veronika Engele for winning the ESMO 2025 Best Poster for Psycho-oncology! 💪
#CancerResearch #GivingVoice2Patients
@kingscollegelondon.bsky.social
CSO was at #ESMO2025 today, hosting a symposium to discuss our work in advancing patient-centred cancer care, and how best to engage colleagues and the broader community in Europe and beyond.
#CommonSenseOncology #CancerCare
@winettevandergraaf.bsky.social @qol.eortc.org @rachriechelmann.bsky.social @madelinepe.bsky.social
17.10.2025 20:04 — 👍 1 🔁 1 💬 0 📌 0
👉 We continue this exciting day at #ESMO25 with a spotlight on patient engagement!
Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes.
📢 Don't miss it!
#Oncology #PatientEngagement #EORTC
👏 Well done to Denis Lacombe for a compelling session today at #ESMO25!
Together, we’re shaping a future of cancer research that’s smarter and more inclusive.
#EORTC #CancerResearch #DEI #ClinicalTrials @myesmo.bsky.social
Today at #ESMO25, EORTC CEO Denis Lacombe speaks on two key challenges in cancer research:
➡️ Are we using therapies optimally in real-world care?
➡️ Are clinical trials truly inclusive of all patients?
Two sessions, one goal: research that’s both effective and equitable.
#ClinicalTrials #DEI
👏 Huge congrats to Madeline Pe for her fantastic presentation at #ESMO25!
Sharing key outcomes from the SISAQOL-IMI initiative and putting patient voices at the heart of cancer research.
Proud moment for EORTC! 📸
#QualityOfLife #EORTC #CancerResearch #GivingVoice2Patients @qol.eortc.org
💪 Looking forward to the presentation by @madelinepe.bsky.social on the SISAQOL-IMI initiative shortly at #ESMO25!
#QualityofLife #GivingVoice2Patients
@eortc.org
ESMO 2025: A leadership moment!
EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action.
Sharing ideas, energy, and a vision for better cancer care across Europe.
Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.
📍We are in Berlin for #ESMO25. Come and visit us at our booth #S4040.
Don't miss EORTC's upcoming sessions, mini-oral sessions, posters and more. Stay tuned!
👉 More info: www.eortc.org/blog/2025/10...
@myesmo.bsky.social #EORTC #ClinicalTrials #CancerResearch #Oncology #TreatmentOptimisation
🎤 Proud moment for the @eortc.org #QualityofLife Group at #ESMO25!
Our members are sharing key insights on patient-reported outcomes & quality of life in #CancerResearch — advancing how we measure what truly matters to patients.
Don’t miss their presentations 👇
www.eortc.org/blog/2025/10...
👏 Looking forward to the presentations from @eortc.org #QualityofLife Group members Ogechukwu Edeh-Asogwa & Josien Scheepens this week at @eanoassociation.bsky.social 2025!
More info 👇
www.eortc.org/blog/2025/10...
#EANO2025 #NeuroOncology #CancerResearch
#GivingVoice2Patients
🎀 Supporting #PinkOctober & progress in #BreastCancer care.
👏 We are proud to have contributed to the update of the QLQ-BR23 into the QLQ-BR42, advancing how breast cancer patients' #QualityofLife is measured.
🔗 Learn more about @eortc.org's work & #EBCC15: www.eortc.org/blog/2025/10...
🌟 Looking forward to the @csoncol.bsky.social symposium at #ESMO2025 and to the contributions from @eortc.org President @winettevandergraaf.bsky.social and our EORTC colleagues @madelinepe.bsky.social and Chris Cronin 👏
More info 👇
#GivingVoice2Patients #CancerResearch #QualityofLife
📅 Save the date for the next @eortc.org #QualityofLife Group meeting!
Our spring 2026 meeting will take place on 16 & 17 April in Berlin ✨
🔎 More info incl. on programme and registration will be made available in early 2026 here: www.eortc.org/event/eortc-...
#QLGmeeting #GivingVoice2Patients
🚀 Our Annual Newsletter is out!
This year's edition features the growing role of Health Economics & HTA within the @eortc.org #QualityofLife (QoL) Group & QoL Department.
💬 It also includes inspiring insights from long-standing members.
📖 Read more: qol.eortc.org/newsletters/
#GivingVoice2Patients
👏 Honoured to see our colleague Claire Piccinin share @eortc.org perspectives at the NASEM Cancer Policy Forum today.
Her talk will highlight how patient-reported outcomes can shape research and care that is truly patient-centred 💪
#GivingVoice2Patients #QualityofLife
More info 👇
Very interesting session with speakers from Japan, India, Slovenia, Jordan, South Africa and South Korea.
Language matters, cultural sensitivity even more, particularly in Quality of Life Research. There’s work to do!
Happy to have introduced the topic showing other global activities @eortc.org
👏Another great meeting of @eortc.org #QualityofLife Group coming to an end.
Many projects, collaborations, inspiring discussions &exchanges of ideas💡
Thank you for joining us, see you in Berlin in April 2026!
#QLGmeeting #GivingVoice2Patients
@mogensgroenvold.bsky.social @dirkhofmeister.bsky.social
💡 Insightful panel discussion as part of @eortc.org #QualityofLife Group autumn meeting closing plenary session.
We look forward to broadening our collaborations in global context🤝
#QLGmeeting #GivingVoice2Patients
@winettevandergraaf.bsky.social @miekevhr.bsky.social
www.eortc.org/event/eortc-...
Excited to host - for the third time - this meeting of a scientific group that I joined in 1989, and which has since made a very substantial contribution to its field.
26.09.2025 06:55 — 👍 2 🔁 1 💬 0 📌 0
👏🏼 Welcome to the @eortc.org #QualityofLife Group autumn meeting 2025 in sunny Copenhagen! 🇩🇰
We have a packed room for the welcome session and a busy programme for the two days ahead - looking forward to another productive meeting! 💪🏼
#GivingVoice2Patients #QLGmeeting
🌟Attending the 3rd International Multidisciplinary Anal Cancer Conference (IMACC 2025) in Leeds today &tomorrow?
Don't miss the 3 poster presentations & mini oral presentation by our @eortc.org #QualityofLife Group members Samantha Sodergren & Daniel Aze 👇
More info: english.events/imacc2025/co...
📢 Attending #EAPM2025 this week?
Today, our @eortc.org #QualityofLife Group member Ines Rathgeber will report on the development of an e-learning course focusing on the use of EORTC PRO measures for quality of life assessment in clinical practice 👇
eapm.eu.com/2025-eapm-co...
#CancerResearch
👏 Proud to see this new policy review by Ian Tannock et al. in
@thelancetoncol.bsky.social!
It highlights the need for standardised HRQoL responder criteria for better patient care & clinical decision-making.
👉 eortc.org/blog/2025/09...
#QualityofLife #GivingVoice2Patients
@madelinepe.bsky.social
🎯 New date!
Join EORTC on 24 Sept 2025 for Treatment Optimisation: Making Cancer Treatment Accessible & Sustainable in Europe, hosted by Mrs Tilly Metz at the @europarl.europa.eu.
🗓️ 24 Sept
📍 EU Parliament & online
🔗 www.eortc.org/event/eortc-...
⚠️ Previous registrations are invalid.
📢 Final reminder to please register by 1st September (extended deadline) if you wish to attend the @eortc.org #QualityofLife Group autumn Meeting 2025:
📅 25-26 September
📍 Copenhagen (DK)
🔗 Registration link in invitation email
🔎 Info on programme etc: www.eortc.org/event/eortc-...
#QLGmeeting
🚨Important findings in K Taylor et al. study on life after head & neck cancer: long-term toxicities affect most survivors — highlighting the need for better patient support & tailored follow-up care.
doi.org/10.1002/ijc....
#CancerCare #GivingVoice2Patients #QualityofLife
@uiccofficial.bsky.social
Are cancer treatments truly optimised for patients?
Our CEO, Denis Lacombe, shares why treatment optimisation must be central to cancer care, and how EU policy can help.
🔗 europeancancer.org/resources/ne...
#CancerCare #TreatmentOptimisation
